Clin2
NCT07668999Possibly a fitRecruiting

Study of ZYG24004 for athlete's foot caused by fungus

Tinea Pedis

Part of Infections, Skin clinical trials.

This trial tests a new medication called ZYG24004 for athlete's foot (tinea pedis) caused by specific fungi. It may be a treatment option for people who have not had success with other antifungal treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
64 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You weigh at least 50 kg (male) or 45 kg (female), with a BMI between 18.5 and 28.0
  • You have athlete's foot between your toes that has been confirmed by a lab test
  • Your foot infection is not too severe, with no deep cracks, oozing, or open sores
  • You have not used any antifungal medications (pills or creams) in the last month or longer
  • You are generally healthy with no serious medical conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07245667Recruiting· Phase 2
Tolnaftate stick for athlete's foot study

This trial tests a medicated stick for athlete's foot (tinea pedis). It aims to see if the treatment is safe and works well.

Framingham, Massachusetts
NCT07056660Recruiting
Cold plasma for athlete's foot

This trial tests a new device that uses cold plasma (a gas with charged particles) to treat moderate-to-severe athlete's foot. It may be an option if standard creams haven't worked or you want to try a non-medication approach.

Luoyang, Henan
NCT06869681Not yet recruiting· Phase 4
Comparing two antifungal creams for athlete's foot

This study compares two antifungal creams—sertaconazole and clotrimazole—to see which works better for treating athlete's foot. You may be able to join if you have a confirmed fungal infection and haven't used other antifungal treatments recently.

NCT06771063Recruiting· Phase 2
Testing a new pill for vaginal yeast infections

This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.

Beijing, Beijing Municipality
NCT06327295Recruiting· Phase 2
Testing a new treatment for mild to moderate toenail fungus

This trial tests an investigational medication called ATB1651 for people with toenail fungus (onychomycosis). If you have a fungal infection covering 20% to 60% of one or both big toenails and are in generally good health, you may be able to join.

Christchurch
NCT06689852Recruiting
Study of two treatments for nail fungus

This trial tests two different treatments for fungus that affects the fingernails or toenails. It is designed to see how well the treatments work and if they are safe.

Villeurbanne, France

Hear when a new Tinea Pedis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.